118555-99-0Relevant articles and documents
New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof
-
Paragraph 0498; 0509; 0517, (2017/04/14)
PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.
Development of a model system for the study of long distance electron transfer in peptides
Cordes, Meike,Jacques, Olivier,Koettgen, Agnieszka,Jasper, Christian,Boudebous, Hassen,Giese, Bernd
experimental part, p. 1053 - 1062 (2009/05/30)
We have designed and synthesized a peptide model in which stepwise electron transfer (ET) through amino acid side chains could be observed. An injection system, which generates an electron hole upon laser irradiation, was connected directly to the aromati
PHASEOLOIDIN, A HOMOGENTISIC ACID GLUCOSIDE FROM ENTADA PHASEOLOIDES
Barua,, Arun K.,Chakrabarty, Manas,Datta, Pran K.,Ray, Sarmila
, p. 3259 - 3262 (2007/10/02)
The structure of phaseoloidine isolated from the seeds of Entada phaseolides has been determined as homogentisic acid 2-O-β-D-glucopyranoside by chemical and spectral means.